|Browns rookie LB Mingo still in hospital|
|Saturday, August 17, 2013 12:29 AM|
CLEVELAND — The speedy linebacker is still in the hospital. The change-of-pace running back needs surgery on his broken leg. The starting right guard will miss part of the regular season.
Following an impressive win, the Browns were hurting.
Browns rookie outside linebacker Barkevious Mingo remained at The Cleveland Clinic on Friday, a day after suffering a bruised lung in the first half of an exhibition win against Detroit.
Mingo, the No. 6 overall pick in this year’s draft, will spend a second night in the hospital, where he was taken before the end of the Browns’ 24-6 victory over the Lions. Browns coach Rob Chudzinski said the team doesn’t know how Mingo sustained the injury.
“We looked at the tape,” Chudzinski said Friday. “There wasn’t a big hit that you could see. Obviously he had a number of plays with some contact but it was hard to determine which hit it was.”
Also, Chudzinski announced running back Dion Lewis will need surgery to repair his broken leg. It’s possible the versatile Lewis could be placed on injured reserve and lost for the season.
Chudzinski told reporters the 6-foot, 240-pound Mingo was having trouble breathing before he left the field and was eventually transported by ambulance to the hospital, noting doctors are being cautious with the 22-year-old former LSU star.
“Anytime that there’s that kind of injury they just want to make sure everything is OK in terms of his health and breathing and everything else,” Chudzinski said.
Mingo was on kickoff coverage and the punt return team and he took a few snaps at outside linebacker in the first half before he left the field and went to the locker room, escorted by a team trainer.
Mingo has been working with the second-team defense but the Browns expect to him to get significant playing time this season as part of their deep rotation of outside pass rushers.
He was one of five Browns players injured in Cleveland’s second straight win.
Lewis broke his left fibula when he was tackled after catching a pass in the third quarter. Lewis, acquired in a trade from Philadelphia in March, has shown flashes of being a perfect complimentary back behind Trent Richardson, who made his exhibition debut against the Lions and rushed for 33 yards in two series.
“He’s one of the guys that had had an opportunity to show what he could do, really catching our eye,” Chudzinski said.
It’s been a tough week for Cleveland’s running backs.
On Monday, Montario Hardesty dislocated his right thumb and then underwent arthroscopic knee surgery on Thursday. Brandon Jackson will likely move up the depth chart into Lewis’ spot until the Browns decide their next move.
Also, starting right guard Jason Pinkston sustained a high ankle sprain when teammate John Greco rolled over him on Cleveland’s second offensive series. Pinkston, who missed most of last season after developing blood clots in his lungs, will likely miss “the early part of the regular season,” Chudzinski explained.
Browns tight end Gary Barnidge sprained his shoulder and rookie kicker Brandon Bogotay, who is competing with veteran Shayne Graham, sprained his groin.
With Lewis and Pinkston expected to miss significant time, Chudzinski added it’s possible the Browns will sign a running back and guard.
Pinkston was filling in for Shawn Lauvao, who underwent surgery on his ankle last week and will also miss some regular-season games. Rookie guard Garrett Gilkey was pressed into action against Detroit’s strong defensive line and more than held his own.
NOTES: Chudzinski still isn’t ready to name his starting quarterback despite Brandon Weeden having his second straight strong outing. Weeden is 18-of-25 for 229 yards and three touchdowns in the preseason. Earlier this week, Chudzinski described the competition between Weeden and backup Jason Campbell is being “close.” He’s not changing his public tune. … Chudzinski said he would like to give Bogotay and Graham more opportunities in the preseason before naming a starter to replace Phil Dawson. … Chudzinski named Weeden, TE Jordan Cameron (two TD catches), LB Jabaal Sheard, DT Phil Taylor and S Josh Aubrey as players who “stood out” against the Lions.
Source: Appeals ’final hurdle’ to HGH test in NFL
The “final hurdle” to testing players for HGH this season apparently involves the NFL and union agreeing on whether Commissioner Roger Goodell will hear appeals for violations other than a positive test, according to a person who works for the league.
The person sent an e-mail Thursday to The Associated Press to update the status of negotiations between the league and the NFL Players Association. The information was provided on condition of anonymity because the sides’ talks about the drug policy are supposed to remain confidential.
The person wrote that while several issues standing in the way of HGH testing have been resolved, “the final hurdle appears to be” the union’s desire to have someone other than Goodell rule on appeals that involve violations of the law or “demonstrated use” of a performance-enhancing substance without a positive test.
The email adds that the NFL does not “believe it is appropriate further to limit the commissioner’s disciplinary authority.”
It also reads: “We have made clear to the NFLPA … that we are not prepared to resolve issues relating to HGH on a piecemeal basis. Two years after agreeing to HGH testing in the first place, we think the goal should be to reach a comprehensive agreement on all aspects of HGH testing so that the program can be fully implemented for the current season.”
The league and union originally paved the way for HGH testing in the 10-year collective bargaining agreement they signed in August 2011, pending discussions to resolve various details. But two Super Bowls have come and gone — and the 2013 regular-season opener is only three weeks away — without a single blood test for human growth hormone having been administered.
Since the current CBA went into effect, the sides have haggled over several aspects of the program, including the appeals process and the union’s insistence on a population study to determine what constitutes a naturally occurring amount of HGH in NFL players.
A memo sent to players by the NFLPA this week — and obtained by the AP — indicated that the population study process was settled, as was a tentative agreement to randomly test 40 players per week during the season. Thursday’s e-mail from the NFL employee refers to those as “agreed-upon elements regarding HGH testing.”
It also notes that the scientific experts in charge of determining a threshold for a positive test “plan to create a control group in addition to the pool of current player specimens” but says “there is presently no agreement of any kind involving a role for retired players in the study.”